Cynovit    1 Injection Bangladesh - English - DGDA (Directorate General of Drug Administration)

cynovit 1 injection

chemist laboratories ltd. - cyanocobalamin - injection - 1 mg/ml

Cynovit 1mg/1ml Injection United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

cynovit 1mg/1ml injection

julphar drug store l.l.c united arab emirates - 5's (1ml ampoule x 5) - injection - 1mg/1ml - nutrition , blood-vitamins

CYNOVITE PLUS CAPSULES (RENEWAL) (OTC) Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

cynovite plus capsules (renewal) (otc)

vitamin a 10.000iu, vit d 1000i.u, vit b1, vit b2, niacin 100mg, vit c 150mg, folic acid 200mcg

DEPO-MEDROL methylprednisolone acetate 40 mg/1 mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

depo-medrol methylprednisolone acetate 40 mg/1 ml injection vial

pfizer australia pty ltd - methylprednisolone acetate, quantity: 40 mg/ml - injection, suspension - excipient ingredients: sodium hydroxide; sodium chloride; miripirium chloride; hydrochloric acid; macrogol 3350; water for injections - indications as at 9 november 1993: a. for intramuscular administration: when oral therapy is not feasible and the strength, dosage form and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intramuscular use of depo-medrol is indicated as follows: 1. endocrine disorders: primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone acetate is the drug of choice; synthetic analogues may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance). acute adrenocortical insufficiency (hydrocortisone or cortisone acetate is the drug of choice; mineralocorticoid supplementation may be necessary, particularly when synthetic analogues are used). preoperatively and in the event of serious trauma or illness, in patients with known adrenal insufficiency or when adrenocortical reserve is doubtful. congenital adrenal hyperplasia. hypercalcaemia associated with cancer. no

COPAXONE glatiramer acetate 40 mg/1 mL solution for injection prefilled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

copaxone glatiramer acetate 40 mg/1 ml solution for injection prefilled syringe

teva pharma australia pty ltd - glatiramer acetate, quantity: 40 mg - injection, solution - excipient ingredients: mannitol; water for injections - copaxone is indicated for the: 1- reduction of the frequency of relapses in patients with relapsing remitting multiple sclerosis. 2-treatment of patients with a single clinical event suggestive of multiple sclerosis and at least two clinically silent mri lesions characteristic of multiple sclerosis, if alternative diagnoses have been excluded.